5-HT6 Receptor Antagonists: Potential Efficacy for the Treatment of Cognitive Impairment in Schizophrenia

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|26|3739-3759

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.26, 2015-01, pp. : 3739-3759

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

5-HT6 Receptor Antagonists as Potential Therapeutics for Cognitive Impairment

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 2, 2010-02 ,pp. : 207-221

Bentham Science Publishers

Access to resources Recommend Favorite

The Potential Utility of 5-HT1A Receptor Antagonists in the Treatment of Cognitive Dysfunction Associated with Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 8, Iss. 2, 2002-01 ,pp. : 139-145

Bentham Science Publishers

Access to resources Recommend Favorite

Recent progress in 5-HT6 receptor antagonists for the treatment of CNS diseases

By Slassi Abdelmalik   Isaac Methvin   O’Brien Anne  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 4, 2002-04 ,pp. : 513-527

Informa Healthcare

Access to resources Recommend Favorite

Serotonin 5-HT6 Receptor Antagonists for the Treatment of Alzheimer's Disease

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 12, 2008-08 ,pp. : 1035-1048

Bentham Science Publishers

Access to resources Recommend Favorite

Serotonergic 5-HT6 Receptor Antagonists: Heterocyclic Chemistry and Potential Therapeutic Significance

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 17, 2015-09 ,pp. : 1643-1662

Bentham Science Publishers

Access to resources Recommend Favorite